Marshall Wace North America’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.26M Sell
93,079
-16,590
-15% -$235K 0.01% 848
2021
Q2
$1.57M Buy
+109,669
New +$1.59M 0.01% 882
2021
Q1
Sell
-55,904
Closed -$1.05M 1798
2020
Q4
$1.05M Buy
+55,904
New +$912K ﹤0.01% 939
2020
Q1
Sell
-878,201
Closed -$17.7M 1628
2019
Q4
$17.7M Buy
+878,201
New +$16.3M 0.09% 215
2018
Q4
Sell
-92,068
Closed -$3.37M 1655
2018
Q3
$3.37M Buy
+92,068
New +$3.46M 0.02% 390
2018
Q1
Sell
-6,193
Closed -$262K 1722
2017
Q4
$262K Buy
+6,193
New +$237K ﹤0.01% 1251
2017
Q2
Sell
-67,678
Closed -$2.64M 1478
2017
Q1
$2.64M Buy
+67,678
New +$2.73M 0.02% 524
2013
Q4
Sell
-84,384
Closed -$3.22M 845
2013
Q3
$3.22M Buy
+84,384
New +$2.97M 0.1% 211

Other funds holding VTRS

Marshall Wace North America's VTRS Position: Q3 2021 in Review

Marshall Wace North America reduced its Viatris (VTRS) stake by 15% in Q3 2021, selling an estimated $235K and leaving 93,079 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #848.

Marshall Wace North America first reported a position in VTRS in Q3 2013 and has held it in 8 quarters since. The position peaked at $17.7M in Q4 2019. 1,017 funds tracked by Wall St. Rank hold VTRS as of Q3 2021.

  • Marshall Wace North America held 93,079 shares of Viatris worth $1.26M as of Q3 2021.
  • Marshall Wace North America sold 16,590 Viatris shares in Q3 2021, an estimated $235K.
  • Viatris made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #848 holding.
  • Marshall Wace North America first reported a position in Viatris in Q3 2013 and has held it in 8 quarters since.
  • Marshall Wace North America's Viatris position peaked at $17.7M in Q4 2019.
  • 1,017 funds tracked by Wall St. Rank held Viatris as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.